Currently, most renal masses are detected incidentally while still small in size because of the widespread use of radiological imaging, and most pheochromocytomas are localized in the adrenal glands as unilateral lesions. A 5 x 4-cm right adrenal mass and a 19 x 13-mm exophytic left renal mass were synchronously detected by contrast enhancement on computed tomography and magnetic resonance imaging in a 47-yearold male with hypertension. The patient's preoperative serum and 24-h urine catecholamine levels were elevated. Initially, robotic transperitoneal right adrenalectomy was performed, and histopathology confirmed a 4 cm pheochromocytoma. After 3 months, transperitoneal zero ischemia robotic left partial nephrectomy was performed, and histopathology demonstrated clear cell renal cell carcinoma, Fuhrman grade II, 17 mm in size with clear surgical margins. This case indicates that sequential robotic surgery is feasible and safe as a minimally invasive approach to remove bilateral renal and adrenal masses. Zero ischemia robotic partial nephrectomy is also feasible and safe for selected small renal masses.
Introduction
Currently, most renal masses are detected incidentally while still small in size because of the widespread use of radiological imaging modalities. [1] Most pheochromocytomas are localized to the adrenal glands as unilateral mass lesions and more frequently involve the right adrenal gland. [2] Minimally invasive surgery is increasingly being applied in the management of adrenal and renal masses, including laparoscopic [3] [4] [5] [6] [7] and robot-assisted laparoscopic approaches. [8] [9] [10] [11] [12] [13] [14] [15] Here we present a challenging case of synchronously detected right adrenal and left renal masses resected via sequential robotic right adrenalectomy and zero ischemia off-clamp left partial nephrectomy.
Case presentation
The patient provided written consent for use of his information in this report. A 47-yearold male patient who had a headache for 2 months underwent evaluation for hypertension at another institution. Abdominal ultrasound, computed tomography, and magnetic resonance imaging (MRI) with contrast enhancement revealed a 5 x 4 cm right adrenal mass and a 19 x 13 mm exophytic left renal mass (Figures 1-3 ). Vanillylmandelic acid, epinephrine, norepinephrine, metanephrine, and normetanephrine levels were elevated in blood and 24-h urine tests. The patient was admitted to our institution with a diagnosis of right pheochromocytoma and a concomitant left renal mass and requested to undergo robotic surgery. His body mass index was 23.2 kg/m 2 .
Initially, robotic transperitoneal right adrenalectomy was performed using the Da Vinci-S 4-arm surgical robotic system (Intuitive Surgical, Sunnyvale, CA, USA). Overall, 5 trocars were used ( Figure 1 ). The adrenal mass was identified, and manipulation of the lesion was avoided to prevent intraoperative hypertension crisis. The adrenal vein draining into the vena cava inferior was identified, dissected meticulously, and cut after application of polymer ligation endoclips 
Discussion
Minimally invasive surgical approaches, including laparoscopic and robot-assisted laparoscopic approaches, are increasingly being applied in the surgical management of adrenal and renal masses. In our case, we used a robotic approach rather than laparoscopy because our patient particularly requested to undergo robotic surgery. However, we would like to state that adrenalectomy and partial nephrectomy procedures could have been performed via a laparoscopic approach. Regarding the laparoscopic approach, both procedures could be performed by either transperitoneal or retroperitoneal approaches depending on the surgeon's preference or patient factors. On the other hand, the robotic approach has the advantages of enabling quicker tis- sue dissection, reconstruction, and intracorporeal suturing with 3-dimensional optical magnification, dexterity in motion, and the ability to perform tremor-free and delicate movements with 3 independent robotic arms in addition to the camera arm for the console surgeon.
One could argue that in our case both procedures could be performed in the same session or in sequential sessions. We performed robotic adrenalectomy and RPN in sequential sessions, because we considered that it would be safer to perform these approaches sequentially. We believed that if postoperative bleeding occurred, it may be difficult to identify the bleeding site and thereby achieve the correct management. However, this decision also depends on the surgeon's preference. In our patient, both robotic procedures were performed by the same console surgeon (AEC). When lesions appear on the same side, such as an adrenal mass and a small renal mass located on the same side, one can perform the procedures in the same robotic session. Performing adrenalectomy initially would be beneficial in order to obtain the desirable blood pressure before performing RPN, which would also prevent unnecessary bleeding.
More than one robotic procedure in the same robotic session has been shown to be feasible and safe in the literature. As an example, Malley et al. [16] reported that synchronous robotic bilateral adrenalectomy is feasible and safe through a transperitoneal approach. Following completion of the procedure on one side, the patient was repositioned and the robot was dedocked in order to operate on the other side. On the other hand, Taskin et al. [17] reported that adrenalectomy via a robotic bilateral posterior retroperitoneal approach is safe and feasible. Although successful outcomes have been reported for bilateral robotic adrenalectomy in the literature, it is not very easy to draw strict conclusions because almost all publications to date have been case reports. Successful outcomes for simultaneous bilateral RPN have also been reported in the literature, again in case reports. [18, 19] Our search found no reports related specifically to synchronous RPN and contralateral adrenalectomy in the same patient. We propose that the decision to perform these 2 procedures in the same robotic session depends on the surgeon's decision and patient factors. Certainly, simultaneous surgery would The number of publications related to zero ischemia off-clamp RPN is increasing in the literature as this approach attracts attention. The zero ischemia approach avoids complete renal ischemia and is thus expected to have a positive impact on postoperative renal function. In our case, the tumor size was small (<2 cm) and the renal mass was exophytic. Therefore, the console surgeon decided to perform RPN without clamping the renal artery. The procedure was completed successfully with an intraoperative blood loss of 100 cc. The surgical robot enabled the console surgeon to perform tissue reconstruction and intracorporeal suturing easily, facilitating the procedure a great deal. However, the renal artery and vein were isolated before the surgeon began performing off-clamp RPN, and a laparoscopic bulldog clamp was ready to be applied in case any significant bleeding occurred. In a retrospective study comparing perioperative outcomes of superselective (n=58) versus main renal artery (n=69) control during RPN, Desai et al. [20] stated that RPN with superselective vascular control enables tumor excision without any global renal ischemia. In their study, blood loss, complications, and positive surgical margin rates were low and similar to those with main artery clamping. Recently, a novel technique of eliminating renal ischemia during RPN using near-infrared fluorescence (NIRF) imaging was described. [21] Targeted tertiary/higher-order tumor-specific arterial branches were controlled with robotic bulldog(s) or neurosurgical aneurysm micro-bulldog(s). Thereafter, indocyanine green dye was given, and NIRF imaging was used to confirm superselective ischemia, defined as a darkened tumor/peritumor area with green fluorescence in the remaining kidney. [21] This technique was suggested to be a safe alternative to conventional RPN with main renal artery clamping that eliminates global renal ischemia. Therefore, with the development of new technological advancements, zero ischemia RPN may be performed more frequently in suitable and selected cases.
Lastly, an excellent cosmetic outcome is another advantage of robotic surgery, particularly in comparison with open surgery, and our patient was very satisfied with the outcome of his robotic surgical experience. Although the operative areas, including those of right adrenalectomy and left partial nephrectomy, were clearly viewed via abdominal MRI at the 6-month postoperative follow-up examination in our patient, other less expensive abdominal imaging modalities, including ultrasound, also could be performed.
In conclusion, pheochromocytoma is one of the causes of hypertension that can be treated surgically, and robotic surgery is a minimally invasive surgical option. Incidentally detected small renal masses can be malignant, and both these diseases can occur simultaneously in the same patient. Zero ischemia off-clamp RPN appears to be a safe and feasible surgical approach in the surgical management of these tumors and offers the advantage of avoiding complete renal ischemia. Although synchronous robotic surgery could be applied, a sequential approach is safe and can be used depending on the surgeon's decision.
